Akers Biosciences Share Discussion Threads

[mcmather] 19/12/2014 15:25

Rivaldo, if this comes good then great. However, have a look through this entire thread and the previous thread/s and the running theme is as per OD's post 2664.

These posts of late - work out for yourself if norbus has a fair knowledge here if he went over and spoke with the previous ceo when considering the size of the company at that time - are essentially as a result of concerns that history is repeating itself; ie yes, we're on cusp.....cash generative in 2014....this is the reason for our woeful performance but Q4 2014 will be the best ever....hoodwink, etc.

Now either Dr Walt is an extremely poor businessman judging by this year's performance given the funds available from the placing and the products that were already commercialised as of Jan 2014. Or a very 'clever' one; jam tomorrow / $300k this year / mug punters?

The next post copies some posts from a poster called Patient analyst from Dec 2011 - ie precisely 3 TEARS AGO; its worth reviewing all of his posts and then reviewing where Akers Biosciences is today - ie Q3 2014 - performance wise.

[rivaldo] 19/12/2014 13:47

Cheers CMB. It's good to have someone else on this thread who doesn't revert to accusation, name-calling or moaning at every opportunity.

[norbus] 19/12/2014 11:35

An oiler, talking to bioscience exhibitors at Florida show he can't name on recruiting ! Bananas we have no bananas today? rivaldo: do you work for the mug fundmanager brought in by Tom N who took 6% pre NASDAQ ? sounds like it; what a pathetic launch that turned out to be ..There but for the grace ...

[callmebanana] 19/12/2014 11:00

Correct my friend

[rivaldo] 19/12/2014 10:59

CMB, I assume your post is relating to and agreeing with mine rather than Norbus's?!

[norbus] 19/12/2014 09:32

Believe what you will rivaldo; did you ever visit New Jersey?

[rivaldo] 19/12/2014 08:46

Excellent post 2669 Monsieur Banana, cheers - any other info you might pick up would be appreciated.

Looking at Banana's prior posts he appears to be a reliable and sensible poster who makes useful and informative contributions on other company threads. Which makes a change from the contributions of certain other regular posters on this thread :o))

[norbus] 19/12/2014 03:59

Hi again Banana , aka Dr Raymond Mitty, akka Dr Akers

you are now set for a comfortable retirement; Is that why Tom left because he really wanted to grow the business, a risky proposition?

Which show would that be , where as if by magic, someone came up to you and whispered sweet things in your ear and told you, snippet snippet , all about AKR.

[norbus] 19/12/2014 03:58

hello Banana

aka

Dr akers

[callmebanana] 18/12/2014 17:48

UK based but work in US frequently and have many contacts going back over 25 years. I can confirm that AKR have strengthened their sales force considerably, now they would not be doing that unless they are serious about increasing market share etc. - this is another snippet I picked up yesterday in a trade show in Florida.

[werewolfie] 18/12/2014 17:47

"the already established distribution channels in the US, China, India, Australia and the Middle East"

A grand pompous sweeping statement - its hardly all the tea in China Dr Walt is distributing is it? Hardly a sausage so far!

[norbus] 18/12/2014 13:06

mcm

so sorry it turned out like this; i could not believe Tom went after he got them to survive and into NASDAQ. something stinks. come to ITM or CAP .you will recoup

[mcmather] 18/12/2014 13:00

Rivaldo, look at the chart above for the stock price since AKER listed on nasdaq re thoughts and impressions of US investors.

Ask those who participated in the offering what they think of the very quietly issued options which, on any level, have absolutely no justification. Or whether they are more impressed by a bit of glitzy PR without substance?

Some general research on Dave the Rave from redchip suggests that he and Dr Walt may well be cut from the same cloth.

[rivaldo] 18/12/2014 12:18

Finncap reiterate their 310p target price after today's news (they also note in today's update the $10.2m net cash pile):



Opaldouglas, I suspect the US investor mentality welcomes such PR as enterprising and proactive. Rather different to here.

And with the NASDAQ listing AKR as a microcap over there needed some initial attention - I doubt Redchip will continue to be used after sufficient time has elapsed.

[opaldouglas] 18/12/2014 09:30

Great products, great prospects but i just can't take the good doctor seriously.

I think Akers would have more credibility if they stopped paying Redchip for PR as it is frankly embarrassing watching those videos.

OD

[mcmather] 18/12/2014 09:23

Here is some other commentary from Dr Raymond Akers:

Dr Ray Akers said, "Today's agreement represents the most significant step to date in our strategy to penetrate a large segment of the healthcare market. There is a clear medical need for our breakthrough test for Heparin / Platelet Factor-4 antibodies. This alliance is all about making our product widely available and greatly increasing our share of voice in the marketplace."

Problem being this is from the RNS dated 5 SEPTEMBER 2005!!?


And since that time Dr Walt has banked nearly $300,000 per year, so nearly $3m....

Just to recap revenue for the last quarter totaled $453,313 with a net loss for the same quarter of $1,055,913.

Dr Walt - who has previously said he is matey with Bill Clinton - recently said "The Board is confident of a strong fourth quarter, contingent on the materialization of international product orders in the pipeline; as well as of a continuing upward trend in PIFA Heparin/PF4 Rapid Assay product sales.

For some reason investors in the UK and the US seem reluctant to take Dr Raymond Akers seriously / at his word?

By the way, still no update of the recent Chinese agreement on the Chinese company's website....

[rivaldo] 18/12/2014 07:59

And lots more in France, Belgium, Netherlands, Switzerland....plus the US, China, India, Australia and the Middle East.

[norbus] 18/12/2014 07:20

They do lots of tests in Lichtenstein

[rivaldo] 18/12/2014 07:19

Excellent news - AKR now have their first European international distribution agreements:



France, Belgium, the Netherlands, Luxembourg, Switzerland and Lichtenstein are hopefully just the start.

Looks like sizeable, respected partners too.

The scale of the opportunity dwarfs the £10.7m m/cap since these add to "the already established distribution channels in the US, China, India, Australia and the Middle East".

[rivaldo] 15/12/2014 09:24

Cheers re the Proactive interview above - here's a direct link:



Good to hear:

- the Novotek deal is a "gamechanger"
- Novotek sales may be minimum $30m and perhaps even greater than Finncap's $67m
- AKR's $10m+ cash pile should remain largely intact until cash break-even
- the Chinese market is even greater than the US's $200m-$400m per annum

[norbus] 13/12/2014 17:28

mcm

For the record, Walter Akers went through $70m before another $15m came in ex NASDAQ; He will enjoy disposing of the remaining $10 cash in a diligent efficient manner with no inconvenience to the stockholders;

AKR will only make money for its stockholders when it develops an instant blow through lie detector test, to be taken by boards of directors before they call for money
or RNS anything; I will go on the record to say I think China deal is not real till you see the money in a US bank

[mcmather] 12/12/2014 16:24

I was hoping to meet up with him one time when he was over here in London but commitments didn't allow sadly. Interesting a meeting I bet and especially with everything that has gone on since.


For the record, today is 11 DECEMBER 2014 and Dr Raymond Akers has just stated in that interview:

"We have $10m worth of cash and do not foresee dipping(?) too much in to that cash before we turn cash flow positive".

[norbus] 12/12/2014 13:06

Just heard the interview ; sounds like a company scripted interview .still do not know if product has regulatory approval in China. Not in the least impressed, sorry

[proactivest] 12/12/2014 12:44

Video interview with chairman Ray Akers



Ray Akers, the co-founder and executive chairman of Akers Biosciences (LON:AKR, NASDAQ:AKER), calls the US$1mln order from China for its Heparin allergy tests a ‘game changer’ for the group.